Michael Dunn

CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA.

Arisan Therapeutics, Inc. develops novel therapeutics for the treatment of neglected and emerging infectious diseases. The private company is based in San Diego, CA.

Aegea Biotechnologies, Inc. is a biotechnology company located in an undisclosed location. Aegea has been granted 11 US patents and 34 foreign equivalents worldwide. The American company's primary focus is on nucleic acid technology innovations, including molecular diagnostic assays, qPCR technologies, sequencing methods, and rapid point-of-care COVID-19 testing. The private company has complementary collaborations with Biocept and Tauriga Sciences for developing and commercializing its COVID-19 tests. The company was founded by Lyle J. Arnold, who has been the CEO since incorporation.

ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases.

ActivX Biosciences, Inc. develops pharmaceutical products. It discovers and develops small molecule drugs for major unmet medical needs. The company was founded in 2000 and is located in La Jolla, CA

Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA.